Servio H Ramirez
Overview
Explore the profile of Servio H Ramirez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
3276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galpayage Dona K, Benmassaoud M, Gipson C, McLaughlin J, Ramirez S, Andrews A
NeuroImmune Pharm Ther
. 2025 Feb;
3(2):97-111.
PMID: 39958876
Although treatable with antiretroviral therapy, HIV infection persists in people living with HIV (PLWH). It is well known that the HIV virus finds refuge in places for which antiretroviral medications...
2.
Sarwer D, Spitzer J, Wu J, LaGrotte C, Griffiths C, Ashare R, et al.
Clin J Sport Med
. 2024 Dec;
35(2):145-151.
PMID: 39630078
Objectives: To determine whether history of traumatic brain injury (TBI) is associated with psychopathology, and, in particular, substance use disorder (SUD) in young adults with a history of athletic participation....
3.
Buzhdygan T, Ramirez S, Nenov M
Front Cell Dev Biol
. 2024 Oct;
12:1476386.
PMID: 39445335
Growing body of evidence suggests that cardiovascular risk factor, asymmetric dimethylarginine (ADMA), can be implicated in the pathogenesis of neurodegenerative and psychiatric disorders. In part, ADMA can affect brain health...
4.
Leonard B, Shuvaev V, Bullock T, Galpayage Dona K, Muzykantov V, Andrews A, et al.
Bioengineering (Basel)
. 2024 Mar;
11(3).
PMID: 38534474
The neuroinflammatory cascade triggered by traumatic brain injury (TBI) represents a clinically important point for therapeutic intervention. Neuroinflammation generates oxidative stress in the form of high-energy reactive oxygen and nitrogen...
5.
Paone L, Szkolnicki M, DeOre B, Tran K, Goldman N, Andrews A, et al.
ACS Appl Mater Interfaces
. 2024 Mar;
16(12):14457-14466.
PMID: 38488736
Most in vitro models use culture medium to apply fluid shear stress to endothelial cells, which does not capture the interaction between blood and endothelial cells. Here, we describe a...
6.
Bullock T, Galpayage Dona K, Hale J, Morales P, Jagerovic N, Andrews A, et al.
NeuroImmune Pharm Ther
. 2023 Dec;
2(4):387-400.
PMID: 38116176
The Cannabinoid 2 Receptor (CB2R) has been found to provide immunological modulation in different cell types. More recently, detection of CB2R in the cerebral endothelium suggests a possible role in...
7.
Galpayage Dona K, Ramirez S, Andrews A
Bioengineering (Basel)
. 2023 Jul;
10(7).
PMID: 37508844
More than a billion people are affected by neurological disorders, and few have effective therapeutic options. A key challenge that has prevented promising preclinically proven strategies is the translation gap...
8.
Ramirez S, Hale J, McCarthy S, Cardenas C, Galpayage Dona K, Hanlon K, et al.
Hum Gene Ther
. 2023 Jun;
34(15-16):682-696.
PMID: 37376759
Neurodegeneration and cerebrovascular disease share an underlying microvascular dysfunction that may be remedied by selective transgene delivery. To date, limited options exist in which cellular components of the brain vasculature...
9.
Vagnozzi A, Li J, Chiu J, Razmpour R, Warfield R, Ramirez S, et al.
Mol Psychiatry
. 2023 Jan;
28(4):1828.
PMID: 36697754
No abstract available.
10.
DeOre B, Tran K, Andrews A, Ramirez S, Galie P
J Neuroimmune Pharmacol
. 2021 Oct;
16(4):722-728.
PMID: 34687399
The SARS-CoV-2 spike protein has been shown to disrupt blood-brain barrier (BBB) function, but its pathogenic mechanism of action is unknown. Whether angiotensin converting enzyme 2 (ACE2), the viral binding...